Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

Keeping a slimmer waistline plus taking regular exercise is far more effective at slashing the risk of cancer than just doing one or the other, according to a large study.New research funded by the ...